OXACILLIN SODIUM

Search structure
Trade Names:
Synonyms:
Status: Approved (1971)
Entry Type: Small molecule
Molecule Category: Salt
UNII: G0V6C994Q5
Parent Compound: OXACILLIN

Structure
InChI Key VDUVBBMAXXHEQP-SLINCCQESA-M
Smile Cc1onc(-c2ccccc2)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.[Na+]
InChI
InChI=1S/C19H19N3O5S.Na/c1-9-11(12(21-27-9)10-7-5-4-6-8-10)15(23)20-13-16(24)22-14(18(25)26)19(2,3)28-17(13)22;/h4-8,13-14,17H,1-3H3,(H,20,23)(H,25,26);/q;+1/p-1/t13-,14+,17-;/m1./s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C19H20N3NaO6S
Molecular Weight 441.44
AlogP 1.9
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 4.0
Polar Surface Area 112.74
Molecular species ACID
Aromatic Rings 2.0
Heavy Atoms 28.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Penicillin-binding protein inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Osteomyelitis 0 D010019 ClinicalTrials

Related Entries

Scaffolds

Parent

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
14.04
Skin and subcutaneous tissue disorders
10.34
Injury, poisoning and procedural complications
8.1
Nervous system disorders
7.32
Infections and infestations
7.24
Vascular disorders
7.24
Cardiac disorders
6.12
Immune system disorders
6.12
Blood and lymphatic system disorders
5.6
Musculoskeletal and connective tissue disorders
4.74
Investigations
3.36
Metabolism and nutrition disorders
3.36
Gastrointestinal disorders
2.93
Hepatobiliary disorders
2.58
Pregnancy, puerperium and perinatal conditions
2.58
Renal and urinary disorders
2.24
Psychiatric disorders
2.15

Cross References

Resources Reference
ChEBI 7810
ChEMBL CHEMBL3989567
EPA CompTox DTXSID50273924
FDA SRS G0V6C994Q5
PubChem 23694213
SureChEMBL SCHEMBL720235
CONTENTS